Mission Creek Capital Partners, Inc. Laboratory Corp Of America Holdings Transaction History

Mission Creek Capital Partners, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$197.69 - $227.29 $176,932 - $203,424	895 New	895 $203,000
Q2 2023 Aug 14, 2023	SELL	$211.93 - $241.33 $15,682 - $17,858	-74 Reduced 6.67%	1,035 $249,000
Q1 2023 May 12, 2023	BUY	$213.32 - $257.83 $853 - $1,031	4 Added 0.36%	1,109 $254,000
Q4 2022 Feb 13, 2023	SELL	$203.72 - $248.97 $20,372 - $24,897	-100 Reduced 8.3%	1,105 $260,000
Q3 2022 Nov 14, 2022	SELL	$204.81 - $262.19 $3,072 - $3,932	-15 Reduced 1.23%	1,205 $247,000
Q1 2022 May 13, 2022	SELL	$259.82 - $298.18 $1,299 - $1,490	-5 Reduced 0.41%	1,220 $322,000
Q4 2021 Feb 14, 2022	SELL	$271.6 - $314.21 $29,876 - $34,563	-110 Reduced 8.24%	1,225 $385,000
Q1 2021 May 14, 2021	SELL	$204.88 - $255.03 $20,488 - $25,503	-100 Reduced 6.97%	1,335 $340,000
Q3 2020 Nov 13, 2020	SELL	$167.03 - $201.3 $4,175 - $5,032	-25 Reduced 1.71%	1,435 $270,000
Q2 2020 Aug 14, 2020	BUY	$113.31 - $182.44 $165,432 - $266,362	1,460 New	1,460 $243,000
Q1 2020 May 14, 2020	SELL	$104.32 - $195.28 $139,788 - $261,675	-1,340 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$163.48 - $173.61 $219,063 - $232,637	1,340 New	1,340 $227,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Mission Creek Capital Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Mission Creek Capital Partners, Inc. with notifications on news.